1. Home
  2. LCUT vs ALXO Comparison

LCUT vs ALXO Comparison

Compare LCUT & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifetime Brands Inc.

LCUT

Lifetime Brands Inc.

HOLD

Current Price

$4.05

Market Cap

69.1M

ML Signal

HOLD

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$1.32

Market Cap

79.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCUT
ALXO
Founded
1945
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.1M
79.7M
IPO Year
1991
2020

Fundamental Metrics

Financial Performance
Metric
LCUT
ALXO
Price
$4.05
$1.32
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$5.00
$3.30
AVG Volume (30 Days)
36.5K
340.5K
Earning Date
11-06-2025
11-07-2025
Dividend Yield
4.21%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$659,066,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.43
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.89
$0.40
52 Week High
$7.05
$2.27

Technical Indicators

Market Signals
Indicator
LCUT
ALXO
Relative Strength Index (RSI) 67.32 45.70
Support Level $3.49 $1.29
Resistance Level $3.97 $1.56
Average True Range (ATR) 0.20 0.16
MACD 0.08 -0.01
Stochastic Oscillator 92.78 29.45

Price Performance

Historical Comparison
LCUT
ALXO

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S. based company that designs, sources, and sells branded kitchenware, tableware, and other products used in the home and markets its products under brands such as Farberware, KitchenAid, Mikasa, and others. The company markets and sells its products principally on a wholesale basis to retailers. It also markets and sells a limited selection of its products directly to consumers through its Pfaltzgraff, Mikasa, Fred, and Friends, Built NY, and others. Its products include kitchen tools, gadgets, cutlery, dinnerware, and glassware. The segments of the company are the U.S. and International. It derives a majority of its revenue from the U.S. segment. The company derives maximum revenue from Kitchenware products.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: